- Home
- EHTH vs VNDA Comparison
EHTH vs VNDA Comparison
Compare EHTH & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHTH
- VNDA
- Stock Information
- Founded
- EHTH 1997
- VNDA 2002
- Country
- EHTH United States
- VNDA United States
- Employees
- EHTH N/A
- VNDA N/A
- Industry
- EHTH Specialty Insurers
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- EHTH Finance
- VNDA Health Care
- Exchange
- EHTH Nasdaq
- VNDA Nasdaq
- Market Cap
- EHTH 292.7M
- VNDA 282.8M
- IPO Year
- EHTH 2006
- VNDA 2006
- Fundamental
- Price
- EHTH $7.35
- VNDA $4.76
- Analyst Decision
- EHTH Buy
- VNDA Strong Buy
- Analyst Count
- EHTH 4
- VNDA 2
- Target Price
- EHTH $6.38
- VNDA $16.50
- AVG Volume (30 Days)
- EHTH 282.1K
- VNDA 620.0K
- Earning Date
- EHTH 05-06-2025
- VNDA 05-07-2025
- Dividend Yield
- EHTH N/A
- VNDA N/A
- EPS Growth
- EHTH N/A
- VNDA N/A
- EPS
- EHTH N/A
- VNDA N/A
- Revenue
- EHTH $532,409,999.00
- VNDA $198,772,000.00
- Revenue This Year
- EHTH $1.50
- VNDA $14.36
- Revenue Next Year
- EHTH $8.74
- VNDA $44.53
- P/E Ratio
- EHTH N/A
- VNDA N/A
- Revenue Growth
- EHTH 17.56
- VNDA 3.18
- 52 Week Low
- EHTH $3.58
- VNDA $3.86
- 52 Week High
- EHTH $11.36
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- EHTH 37.58
- VNDA 49.19
- Support Level
- EHTH $7.13
- VNDA $4.84
- Resistance Level
- EHTH $7.56
- VNDA $5.04
- Average True Range (ATR)
- EHTH 0.40
- VNDA 0.20
- MACD
- EHTH -0.03
- VNDA -0.02
- Stochastic Oscillator
- EHTH 22.18
- VNDA 25.00
About EHTH eHealth Inc.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare and Employer and Individual. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.